Insider Trading History of Shin Nippon Biomedical Laboratories, Ltd.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Shin Nippon Biomedical Laboratories, Ltd. since 2015. This trader's CIK number is 1657770. At the time of last reporting, Shin Nippon Biomedical Laboratories, Ltd. was the 10% Owner of Satsuma Pharmaceuticals, Inc.. (stock ticker symbol STSA). Also see all insider trading activities at Satsuma Pharmaceuticals, Inc..

Note that in the past Shin Nippon Biomedical Laboratories, Ltd. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Wave Life Sciences Ltd. (WVE) by Shin Nippon Biomedical Laboratories, Ltd.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 WVE 125,000 $2,000,000 0 $0 0 $0

Yearly summary of insider trading at Satsuma Pharmaceuticals, Inc. (STSA) by Shin Nippon Biomedical Laboratories, Ltd.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 STSA 30,477,313 $27,734,354 0 $0 0 $0


Insider trading activities at 2 companies by Shin Nippon Biomedical Laboratories, Ltd.:

1. Wave Life Sciences Ltd. (WVE)

2. Satsuma Pharmaceuticals, Inc. (STSA)

Table 1. Insider trading of Wave Life Sciences Ltd. (WVE) by Shin Nippon Biomedical Laboratories, Ltd.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-11-16 WVE Buy 125,000 16.00 2,000,000

Table 2. Insider trading of Satsuma Pharmaceuticals, Inc. (STSA) by Shin Nippon Biomedical Laboratories, Ltd.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-06-06 STSA Buy 22,053,581 .91 20,068,758
2023-06-08 STSA Buy 8,423,732 .91 7,665,596

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Shin Nippon Biomedical Laboratories, Ltd. (10% Owner of Satsuma Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.